Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C96705
http://purl.obolibrary.org/obo/NCIT_C96705
|
|---|---|
| Preferred Name | Etarotene |
| Definitions |
An ethylsulfonyl derivative of arotinoic acid with differentiation inducing and potential antineoplastic activities. Like other retinoic acid agents, etarotene binds to and activates retinoic acid receptors (RARs), thereby inducing changes in the expression of certain genes leading to cell differentiation and decreased cell proliferation in susceptible cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An ethylsulfonyl derivative of arotinoic acid with differentiation inducing and potential antineoplastic activities. Like other retinoic acid agents, etarotene binds to and activates retinoic acid receptors (RARs), thereby inducing changes in the expression of certain genes leading to cell differentiation and decreased cell proliferation in susceptible cells. |
|---|---|
| prefLabel | Etarotene
|
| label | Etarotene
|
| code | C96705
|
| prefixIRI | NCIT:C96705
|
| in_subset | |
| Preferred_Name | Etarotene
|
| FDA_UNII_Code | PD3817FE9N
|
| Contributing_Source | FDA
|
| Chemical_Formula | C25H32O2S
|
| Maps_To | Etarotene
|
| CAS_Registry | 87719-32-2
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C3272976
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |